1. Clinical Benefit With PARP Inhibitor for Pathogenic Germline FANCA-Mutated Relapsed Epithelial Ovarian Cancer: A Case Report
   Bing Qian et al, 2022, Frontiers in Oncology CrossRef
2. N-glycosylation profiling of serum immunoglobulin in opisthorchiasis patients
   Sudarat Onsurathum et al, 2021, Journal of Proteomics CrossRef